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ABSTRACT Burkholderia pseudomallei, an environmental bacterium that causes the
deadly disease melioidosis, is endemic in northern Australia and Southeast Asia. An
increasing number of melioidosis cases are being reported in other tropical regions,
including Africa and the Indian Ocean islands. B. pseudomallei ﬁrst emerged in Aus-
tralia, with subsequent rare dissemination event(s) to Southeast Asia; however, its
dispersal to other regions is not yet well understood. We used large-scale compara-
tive genomics to investigate the origins of three B. pseudomallei isolates from Mada-
gascar and two from Burkina Faso. Phylogenomic reconstruction demonstrates that
these African B. pseudomallei isolates group into a single novel clade that resides
within the more ancestral Asian clade. Intriguingly, South American strains reside
within the African clade, suggesting more recent dissemination from West Africa to
the Americas. Anthropogenic factors likely assisted in B. pseudomallei dissemination
to Africa, possibly during migration of the Austronesian peoples from Indonesian
Borneo to Madagascar ~2,000 years ago, with subsequent genetic diversity driven by
mutation and recombination. Our study provides new insights into global patterns
of B. pseudomallei dissemination and adds to the growing body of evidence of me-
lioidosis endemicity in Africa. Our ﬁndings have important implications for melioido-
sis diagnosis and management in Africa.
IMPORTANCE Sporadic melioidosis cases have been reported in the African main-
land and Indian Ocean islands, but until recently, these regions were not considered
areas where B. pseudomallei is endemic. Given the high mortality rate of melioidosis,
it is crucial that this disease be recognized and suspected in all regions of endemic-
ity. Previous work has shown that B. pseudomallei originated in Australia, with subse-
quent introduction into Asia; however, the precise origin of B. pseudomallei in other
tropical regions remains poorly understood. Using whole-genome sequencing, we
characterized B. pseudomallei isolates from Madagascar and Burkina Faso. Next, we
compared these strains to a global collection of B. pseudomallei isolates to identify
their evolutionary origins. We found that African B. pseudomallei strains likely origi-
nated from Asia and were closely related to South American strains, reﬂecting a rela-
tively recent shared evolutionary history. We also identiﬁed substantial genetic diver-
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sity among African strains, suggesting long-term B. pseudomallei endemicity in this
region.
KEYWORDS: Burkholderia, epidemiology, infectious disease, melioidosis,
phylogeography, population genetics
The soil-dwelling bacterium Burkholderia pseudomallei is the etiological agent ofmelioidosis, a disease with high mortality rates in humans and many animals (1).
Melioidosis has diverse clinical manifestations and can be difﬁcult to diagnose micro-
biologically, even in technologically sophisticated laboratories (2, 3). Because of the
high mortality rate of melioidosis, which ranges from 10 to 40% even with treatment,
the intrinsic resistance of B. pseudomallei to many antibiotics, the potential for acqui-
sition via the aerosol route, and the lack of an effective vaccine, this bacterium is among
a small group of pathogens listed as Tier 1 Select Agents by the United States
government (1, 4).
The true global distribution of B. pseudomallei remains unclear, although regions not
previously thought to harbor this organism are now being identiﬁed (1, 5–7). Outside
the known hyperendemicity foci of northern Australia and Southeast Asia, B. pseu-
domallei has been sporadically found in most other tropical regions, including Africa,
the Indian Ocean islands, and the Americas (8). It remains unclear whether the spread
of melioidosis beyond the known regions where B. pseudomallei is endemic has
occurred in recent decades or if it is just being unmasked in Africa and the Americas by
better recognition and increased surveillance (9). Several African mainland countries
have reported suspected locally acquired melioidosis cases, including Gabon, Malawi,
and Sierra Leone (10–12), and there are several instances of travelers acquiring me-
lioidosis during visits to Africa (13–15). Cases have also been reported in Madagascar
and the Indian Ocean islands of Mauritius, Seychelles, and La Réunion (16–19). Addi-
tionally, countries in Central and South America, including Brazil, Colombia, Ecuador,
and Honduras, and several islands in the Caribbean, including Guadeloupe, Martinique,
and Puerto Rico, have also reported melioidosis cases (20–31), suggesting that B. pseu-
domallei is endemic in almost all tropical regions across the globe, as recently predicted
by an extensive global modeling study (32).
Although B. pseudomallei has one of the most highly recombinogenic genomes
identiﬁed to date (33), phylogeographic reconstruction and subsequent geographic
attribution of B. pseudomallei populations is possible. The strong geographic signal
present in the B. pseudomallei genome reﬂects its primary mode of transmission;
melioidosis is almost invariably caused by contact with contaminated surface water or
soil, with human-to-human transmission being exceptionally rare. Thus, large geo-
graphic barriers (e.g., the Wallace Line, which separates most of Asia from Australasia)
have substantially restricted gene ﬂow between populations. These factors have led to
distinct Asian and Australasian B. pseudomallei populations that have regionally
evolved over hundreds or thousands of years (33, 34).
Multilocus sequence typing (MLST) is commonly used to study the population
structure of many pathogens, including B. pseudomallei (http://pubmlst.org/bpseu-
domallei), and can be a useful tool for determining the geographic origin of B. pseu-
domallei strains (34, 35). More recently, an inexpensive capillary electrophoresis-based
typing method that exploits size and allelic variations in the 16S-23S rDNA intergenic
transcribed spacer (ITS) region has been used to detect geographic signal and diversity
in B. pseudomallei (36, 37). However, we and others have noted that these typing
methods are unable to determine ﬁne-scale population structure because of low
genotyping resolution and high rates of recombination among local B. pseudomallei
populations (33, 35). In addition, we have shown that MLST can, albeit infrequently,
lead to confounding results because of sequence type (ST) homoplasy (38). Thus,
phylogenetic reconstruction of B. pseudomallei populations using genome-wide single-
nucleotide polymorphisms (SNPs) derived from whole-genome data is needed to
identify the true geographic origins of strains.
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In 2009, using emerging next-generation whole-genome sequencing (WGS) tech-
nologies, Pearson and coworkers were the ﬁrst to hypothesize that B. pseudomallei
originated in Australia, followed by one or more rare transmission events to Southeast
Asia. Using Bayesian inference and molecular clock estimates, Pearson et al. estimated
that B. pseudomallei moved into Southeast Asia during the last glacial period (between
16 and 225 thousand years ago), when the Sahul and Sunda land masses were in closest
proximity because of greatly lowered sea levels. Subsequently, B. pseudomallei has
disseminated to other parts of the globe via similarly rare but signiﬁcant transmission
events (33). This seminal study by Pearson and coworkers was based on relatively few
strains, but subsequent studies across larger and more diverse B. pseudomallei data sets
have supported their initial hypothesis (35, 38, 39). Although the relationship between
Asian and Australian strains has been reasonably well characterized, the origin of
B. pseudomallei in other parts of the world is still poorly understood. Of particular
interest are Africa and the Americas, where melioidosis was once considered sporadic
but is now being unmasked as likely endemic (5). In this study, we aimed to further
characterize the global phylogeography of B. pseudomallei by using large-scale com-
parative genomics to determine the origin of melioidosis in Africa, which has not yet
been investigated on a whole-genome scale.
RESULTS AND DISCUSSION
Phylogenomic analysis identiﬁes an African and South American B. pseudomallei
clade. Comparative analysis of the 144 B. pseudomallei genomes, including the ﬁve new
African genomes generated in this study, identiﬁed 202,245 bi-allelic SNPs among these
strains. These SNPs were used to reconstruct a maximum-parsimony phylogenetic tree
(Fig. 1A). As previously shown (33, 35, 38, 39), we observed a clear distinction between
Australasian (red or green) and Asian (blue) B. pseudomallei strains, which was sup-
ported by a bootstrap value of 74%. The separation of the Australasian and Asian
B. pseudomallei clades is due to the restricted dispersal of B. pseudomallei between
these two geographic regions, with ST-562 being the only example where a recent
overlap between these two regions has been conﬁrmed (39, 40). The African (pink) and
South American (gold) strains all reside on a separate, highly supported (bootstrap
value  100%) branch within the Asian clade.
Interestingly, the three South American strains (4900CFPatient1 [36, 41], 7894 [42],
and BCC215 [24]) share a node with the two Burkina Faso strains, although the Burkina
Faso strains are more closely related to each other than to the South American strains;
in contrast, the three Madagascan isolates reside on a separate branch within the
African-South American clade (bootstrap value  100%). This observation demon-
strates that African and South American B. pseudomallei likely originated from an Asian
ancestor, with no evidence of B. pseudomallei transmission directly from Australia. The
location of the African and South American strains within the Asian clade also conﬁrms
that transmission into Africa must have occurred after the ﬁrst B. pseudomallei trans-
mission from Australia to Asia, which has been estimated to have occurred between
16,000 and 225,000 years ago (33). Further, our analysis hints at African ancestry for
South American strains, with these strains emerging from a relatively recent branch
within the deeper African node (Fig. 1A). This ﬁnding suggests that B. pseudomallei was
transmitted from West Africa to the Americas. Genomic data from additional American
B. pseudomallei isolates will provide much-needed insight into this possibility.
We were next interested in investigating the region in Asia where African B. pseu-
domallei originated. The Asian isolates closest to the African and South American strains
in our phylogeny are B. pseudomallei 576 and PB08298010. However, this branch has
only moderate bootstrap support (61%), likely because of undersampling of this clade
in the current data set, so we were unable to identify the precise origin of this ancestor.
B. pseudomallei 576 was obtained from a 49-year-old female from Bangkok, Thailand,
and B. pseudomallei PB08298010 was isolated from a melioidosis case that occurred in
Arizona, United States, and was speculated to have originated from contaminated
medical supplies imported from Malaysia (35). In support of an Asian origin for
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PB08298010, its MLST proﬁle is ST-426, which matches the ST of MSHR0158, an isolate
from an Australian traveler thought to have acquired melioidosis in Penang, Peninsular
Malaysia (http://pubmlst.org/bpseudomallei). Our global phylogeny also supports an
Asian origin for B. pseudomallei PB08298010, although this strain does not group with
a second Malaysian isolate included in our analysis (MSHR5107). However, unlike
MSHR0158, MSHR5107 was isolated from Sarawak, Malaysian Borneo. ST data show
little overlap between the Peninsular Malaysia and Malaysian Borneo isolates; thus, it is
not surprising that PB08298010 and MSHR5107 do not group together on a whole-
genome level.
Our phylogeny demonstrates support for African strains being of Asian origin,
although a greater number of Asian strains from more diverse locations will enable
more accurate identiﬁcation of the precise origin(s) of African B. pseudomallei. In
particular, there are several suspected regions of endemicity in Asia that have no
representative WGS data in our phylogeny, such as Indonesia, Philippines, and Myan-
mar. Additional isolates from these locations will increase the resolution of these poorly
populated clades and may potentially identify a more precise origin of African B. pseu-
domallei. Of note, genetic analysis of the Malagasy, the indigenous people of Mada-
gascar, shows that approximately half have shared ancestry with Indonesian Borneo
FIG 1 Genetic and genomic comparisons of the African B. pseudomallei isolates with global B. pseudomallei reference strains. (A) Maximum-parsimony
phylogeny of 144 B. pseudomallei genomes. This tree was drawn by using 202,245 core genome, orthologous, bi-allelic SNPs identified by the SPANDx
pipeline (75) and rooted by using MSHR0668. Isolates are color coded by origin as follows: Australia, red; Papua New Guinea, green; Asia, blue; Africa
(including Madagascar), pink; South America, gold. African and South American isolates form their own clade that falls within the more ancestral Asian
clade, which is separate from Australasian B. pseudomallei. Bootstrap values were generated on the basis of 200 replicates. The consistency index is 0.19.
(B) Distribution of ITS types by geographic region. Similarly to earlier studies, isolates from Africa and the Americas show an overrepresentation of ITS
type G in comparison to strains from Australasia and Asia; however, African isolates also possess ITS types CE and C, alleles that are commonly identified
in isolates from regions of Asia and Australasia where B. pseudomallei is hyperendemic.
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people (43). Austronesian migration from Indonesian Borneo to Madagascar is thought
to have occurred between 1,500 and 2,000 years ago (44, 45). This migration provides
a possible date for an anthropogenically driven introduction of Asian B. pseudomallei
into Madagascar and subsequent transfer from Madagascar to the African mainland,
potentially through human migration, trade, or slavery routes. At the time of this
Austronesian migration, pigs were also introduced to Madagascar (46). Pigs are known
to become infected with B. pseudomallei, although they are generally less susceptible
than sheep, goats, or horses (47, 48); it is plausible that pigs acted as a reservoir for this
pathogen, facilitating the transfer of B. pseudomallei into Madagascar. Several studies
have shown that certain bird species may be infected by or commensally carry
B. pseudomallei (47, 49). Therefore, an additional possibility is that B. pseudomallei was
disseminated from Asia to Madagascar by migratory birds ﬂying along the Asia-East
Africa ﬂyway, similar to what has been observed in the introduction of West Nile virus
to the Americas from West Africa (50). Future phylogenomic and molecular clock
investigations using a larger number of strains from Southeast Asia, Africa, and the
Americas will provide further important clues to the origin of B. pseudomallei in Africa
and the Americas.
MLST hints at deeper phylogenetic relationships but is subject to ho-
moplasy. The three clinical isolates from Madagascar belong to STs 1043, 1053, and
1054 (Table 1; see Table S3 in the supplemental material). STs 1043 and 1053 are
single-locus variants, whereas ST-1054 is a double-locus variant of ST-1053 and a
triple-locus variant of ST-1043. All three of these STs share identical ace, lipA, narK, and
ndh alleles but differ at the remaining three loci (gltB, gmhD, and lepA). The two isolates
from Burkina Faso belong to STs 1122 and 1121 and are triple-locus variants of one
another. STs 1122 and 1043 are double-locus variants, although one strain originated
in Madagascar and the other originated in Burkina Faso, a relationship that is poten-
tially misleading and not reﬂected on a whole-genome scale (Fig. 1A). All ﬁve STs are
unique, with no other matches in the B. pseudomallei MLST database, including other
characterized strains from Africa and South America (see Table S3 in the supplemental
material). Although MLST shows some utility for determining strain origin, it can be
unreliable in highly recombinogenic organisms like B. pseudomallei when trying to
determine deeper phylogenetic relationships (51). Such homoplasy has been demon-
strated previously, where B. pseudomallei isolates from Cambodia and Australia were
identical by MLST but differed greatly on a whole-genome level (38), thereby making
TABLE 1 African and American B. pseudomallei isolates used in this study and associated
genotyping information
Strain name Other name(s) STb (allelic proﬁle) ITS type
Geographic origin,
reference (GenBank
accession no.)
11-1617 MSHR7969 1054 (4, 12,
34, 1, 5, 2, 1)
CE Madagascar, 16 (SRR3145392)
11-1696 MSHR7968 1053 (4, 12,
3, 2, 5, 2, 1)
C Madagascar, 16 (SRR3145393)
BEL2013 MSHR7966 1043 (4, 1,
3, 2, 5, 2, 1)
G Madagascar, 62 (SRR3145396)
BF103 ITM BF103,
MSHR7964
1121 (1, 18,
13, 2, 5, 6, 1)
G Burkina Faso (SRR3145394)
BF111 ITM BF111,
MSHR7965
1122 (1, 1,
19, 2, 5, 2, 1)
C Burkina Faso (SRR3145395)
4900CFPatient1 NAa 92 (1, 1,
2, 1, 5, 1, 1)
G Brazil
(ARZE00000000)
7894 7894/300 11 (1, 1,
13, 1, 6, 1, 1)
G Ecuador (CP009535,
CP009536)
BCC215 NA 1355 (1, 156,
2, 2, 5, 1, 1)
G Ceará, Brazil
(ABBR00000000)
aNA, not applicable.
bPer the B. pseudomallei MLST database (http://pubmlst.org/bpseudomallei).
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accurate geographic attribution in these cases impossible without WGS. One conclu-
sion that can be made is that there is considerable underlying genetic diversity in these
regions, a ﬁnding supported by our WGS phylogeny (Fig. 1A) and noted previously in
multiple studies using less highly resolving typing methods (13, 16). This underlying
diversity further supports the notion that the introduction of B. pseudomallei to these
regions is not a recent event, as sufﬁcient time has elapsed since their introduction for
divergence to occur.
ITS typing shows unexpected diversity in African, but not American, iso-
lates. Previously, ITS typing of 1,191 B. pseudomallei isolates revealed that strains from
Africa and the Americas have restricted diversity at the 16S-23S rDNA ITS locus, with a
dominance of the ITS type G allele among these isolates (36, 37). However, prior to this
study, only four African strains had been examined by ITS typing (2002721628 from
Madagascar [ITS type G], 2002721629 and 2002721639 from Kenya [ITS types G and C,
respectively], and 2002721691 from Mauritius [ITS type GC]) (37). Using WGS data, we
determined the ITS genotypes of all of the strains in our data set, including the ﬁve
African strains. Australasian isolates (n  115; MSHR6137 could not be typed because
of a lack of sequence information covering the 16S-23S spacer region) were predom-
inantly ITS type E (53%), followed by ITS type C (33%) and ITS type CE (13%), with a very
small percentage of ITS type G isolates (1%). Asian isolates (n  19; excluding
PB08298010 due to uncertain provenance) were mostly ITS type CE (42%), followed by
ITS type E (37%) and ITS type C (21%). The distribution of Australasian ITS types was
almost identical to that seen previously (37); however, the distribution of ITS types
among Asian strains differed somewhat, most likely because of sampling bias incurred
by our small data set. We did not identify an ITS type G isolate among our Asian strains,
which was expected, given the rarity of type G in Asia (1%) (37). Although the precise
origin of PB08298010 is not known, it has previously been shown to be ITS type G (36).
The three Madagascan isolates were ITS types C, CE, and G, and the two Burkina Faso
isolates were ITS types C and G (Table 1; Fig. 1B). These results reveal further diversity
among B. pseudomallei strains from Africa, with the CE allele not previously reported.
The ﬁnding of an additional ITS type in the African isolates indicates a complex
evolutionary history of B. pseudomallei in this region that is not yet well understood. We
pose three possible explanations for this diversity. First, the introduction of B. pseu-
domallei to Africa from Asia may have occurred as a single transmission event that
involved a mixed population of strains, and thus ITS types, with this ITS diversity
persisting to the present day. Second, multiple introduction events with different
strains may have occurred following several independent dissemination events from
Asia. Third, the ITS region in some strains may have undergone convergent evolution
across distinct geographic regions, perhaps because of similar selective pressures on
B. pseudomallei populations. The ostensible rarity of ITS type G in Asia suggests that the
introduction of this ITS allele to Africa was a highly improbable event, although
comprehensive analysis of ITS allele distribution across Asian isolates, particularly those
from Indonesian Borneo, is currently lacking. To date, ITS type G has been identiﬁed in
only three Thai strains (Songkhla 25 W-1, Songkhla 25 W-2, and Phattalung 52 W-1). This
observation is consistent with the node shared by African strains and Bangkok B. pseu-
domallei 576 on the whole-genome phylogeny, and it is therefore possible that ITS type
G B. pseudomallei in Africa originated from Thailand. All 24 Malaysian strains examined
in the study of Liguori et al. (37) lacked the ITS type G allele, although these isolates
were derived from a historic B. pseudomallei collection and it is therefore unclear what
proportion of these strains, if any, are from Malaysian Borneo. In addition, the heavy
sampling bias toward isolates from Thailand (443/480 [92%] Asian strains) may explain
the low abundance of ITS type G reported to date. Further ITS typing and WGS data
from Bornean and African strains are needed to explore these hypotheses, with such
data likely to assist in the more precise determination of the Asian ancestor of ITS type
G in Africa.
In contrast to the African strains, the 18 American strains characterized by the ITS
typing method have, to date, been genotyped only as ITS type G (36), suggesting a
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genetic bottleneck during B. pseudomallei dissemination from Africa to the Americas.
This ﬁnding is consistent with our genome phylogeny, which hints at recent transmis-
sion of B. pseudomallei from Africa to the Americas. Although the route of this
transmission is highly speculative, one possibility is the movement of West Africans to
South America during the transatlantic slave trade between the 16th and 19th centu-
ries. Using pulsed-ﬁeld gel electrophoresis and MLST, a study of B. pseudomallei isolates
from a 2003 Brazilian melioidosis outbreak showed some genetic diversity among
strains (24), supporting our hypothesis that the introduction of B. pseudomallei to the
Americas did not occur very recently. In addition, our WGS phylogeny conﬁrmed that
the three South American strains are not homogeneous on a whole-genome level
(Fig. 1A). Whether this diversity also extends to the 16S-23S ITS region in other South
American isolates remains to be elucidated.
African B. pseudomallei strains vary in their virulence gene content. B. pseu-
domallei has an impressive virulence arsenal, including capsular polysaccharide I,
lipopolysaccharides (LPS), a diverse complement of autotransporters, multiple special-
ized secretion systems, a lethal toxin, and iron-scavenging siderophores (52). To assess
the virulence potential of African B. pseudomallei strains, assembled genomes were
screened against a large panel of known and putative B. pseudomallei virulence genes
(Fig. 2; see Table S2 in the supplemental material). All African isolates and the two
isolates from Brazil lacked boaB (BPSL1705), which encodes a trimeric autotransporter
adhesin (TAA) that may have a role in macrophage invasion and survival (53); however,
boaB was also absent from 81 other B. pseudomallei strains, including Australian clinical
blood isolate MSHR0668 and Thai clinical liver abscess isolate 1106a (54), and is
therefore unlikely to be a crucial virulence factor. Two additional TAAs were found to
be variably present among the African strains; bpaD (BPSS0088) was absent from all ﬁve
African strains, and BPSL2063 (55) was absent from Madagascan strain BEL2013. Al-
though bpaD was also variably present across the larger data set (absent from ~25% of
the strains), BPSL2063 was conserved across the other 142 genomes and variable in only
one other isolate (B. pseudomallei Pakistan9; BLAST score ratio [BSR]  0.72). The best
characterized TAA, Burkholderia intracellular motility A (encoded by bimA [BPSS1492]),
which is responsible for the actin-based motility of B. pseudomallei (56), was found in
all of the African strains. These strains encoded for the more common bimABp variant,
which is associated with primary pneumonia presentation of melioidosis (57). The less
common variant of bimA, bimABm, is found in ~12% of Australian strains. Outside
Australia, it has been reported in only a single isolate from India (58); the bimABm
variant is strongly associated with neurological melioidosis (57).
In addition to their variable TAA content, the African B. pseudomallei strains were
highly varied at multiple genomic islands (GIs), including at GI16, which encodes two
virulence factors, ﬁlamentous hemagglutinin (fhaB3) and lactonase family protein A
(lfpA) (Fig. 2 and 3). Three out of ﬁve African B. pseudomallei strains contained the
full-length fhaB3 gene; however, BF103 (Burkina Faso) contained a truncated version
(BSR  0.77) and BEL2013 (Madagascar) lacked fhaB3 entirely. The fhaB3 gene is
variably present in B. pseudomallei and was absent from or truncated in 24 additional
FIG 2 Blast score similarity ratios of all of the known virulence markers in B. pseudomallei K96243 compared to the African B. pseudomallei strains. African
strains possess variable virulence gene contents, with trimeric autotransporter adhesions, LPS (wbi cluster), filamentous hemagglutinin (fhaB3), and
lactonase family protein A (lfpA) all showing variability across strains.
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strains across the larger data set. Absence of this gene has been previously associated
with localized skin abscess formation without septicemia, a less severe form of me-
lioidosis that is rarely fatal (57). An additional virulence factor located directly down-
stream of fhaB3, lfpA, is able to modify host macrophage expression to resemble
osteoclastogenesis and is required for full virulence in the Syrian hamster model (59).
The lfpA gene is absent from the two Burkina Faso strains but is present in all three
strains from Madagascar. The presence of lfpA was highly variable across the remainder
of the data set, being absent from ~50% of the strains.
The type II O-antigenic polysaccharide (O-PS; wbi gene cluster) is absent from two
of the isolates from Madagascar (11-1617 and 11-1696). There is an ~14-kb deletion
(genomic coordinates 3,198,200 to 3,211,800 relative to B. pseudomallei K96243 chro-
mosome I), encompassing rmlCD, wzm, wzt, and wbiABCDEFGHI (Fig. 3). Type II O-PS has
previously been shown to be required for serum resistance and virulence in animal
models (60). Interestingly, this locus also shows a propensity for loss-of-function
mutations in a persistent-carriage infection of an Australian patient who has been
colonized with B. pseudomallei for 14 years (61). The type II O-PS is also variably
present across the larger isolate collection, being absent from an additional 18 strains,
so is likely not an essential factor for infection, although it may be required for full
virulence.
It remains uncertain why the reported incidence of melioidosis in both Africa and
the Americas is far lower than that in other regions where it is endemic, such as
Australasia and Thailand. Despite the potential for lower virulence, as shown by the
virulence gene proﬁles, all three cases from Madagascar were blood culture positive
and two were fatal (16, 62), suggesting that African B. pseudomallei strains possess full
virulence. Decreased virulence should not be ruled out; however, other explanations
may account for the low reported melioidosis rates in Africa and the Americas,
including limited awareness of melioidosis in these regions, poor access to modern
diagnostic and laboratory facilities for B. pseudomallei detection, a lower likelihood of
exposure in the general population because of differences in agricultural practices, or
a lower incidence of risk factors in the population (5). A ﬁnal and noncontradictory
FIG 3 Whole-genome comparison of B. pseudomallei African strains aligned with B. pseudomallei K96243 by BLAST ring image generator. The outer ring
shows the locations of the known genomic islands in the B. pseudomallei chromosomes. Also shown is the 13.5-kb deletion of the LPS locus in two of the
Madagascan B. pseudomallei strains, 11-1617 and 11-1696, at positions ~3,198,200 to ~3,211,800 relative to strain K96243.
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factor is that B. pseudomallei may indeed be far less common in the environments of
Africa and South America than in those of northern Australia and Southeast Asia,
although recent modeling suggests that the African and South American environments
are permissive for the presence and persistence of B. pseudomallei (32); environmental
surveillance studies are under way to assess this possibility. Future studies concentrat-
ing on functional virulence assessment and genomic analyses of additional B. pseu-
domallei strains from these regions are needed to ascertain the true rate of melioidosis
and determine if these strains have maintained their full virulence potential.
Conclusions. Despite high levels of recombination in B. pseudomallei, sufﬁcient
signal exists across the genome to robustly determine the geographic origins of strains.
In this study, we used WGS to uncover diverse MLST proﬁles, ITS types, and variation
in the virulence gene content of African isolates. Such diversity strongly supports the
premise of long-term endemicity of B. pseudomallei in Africa and rules out its recent
introduction. Phylogenomic analysis revealed that African B. pseudomallei formed a
separate clade that was closely related to South American strains, with this clade
residing within the deeper Asian clade, suggesting an ancestral Asian origin for
B. pseudomallei in Africa and the Americas. Phylogenomic analysis also showed that the
South American strains emerged more recently within the African clade, an observation
supported by the single ITS type (G) of all of the American isolates characterized to
date. Anthropogenically driven factors provide a plausible explanation for B. pseu-
domallei transmission to these regions, where B. pseudomallei was previously not
endemic.
MATERIALS AND METHODS
Strain selection. Two B. pseudomallei isolates from Madagascar were obtained from clinical cases
occurring in 2012 and 2013 (16), with a third isolate obtained from a French patient in Belgium following
a visit to Mahajanga, a city on the northwestern coast of Madagascar (62). The two Burkina Faso isolates
were both from children who had not traveled outside Burkina Faso and who presented with localized
melioidosis without systemic sepsis. All of the strains used in this study are described in Table 1 (see also
Table S1 in the supplemental material). For phylogenomic analysis, we used 144 B. pseudomallei isolates
from diverse geographic locations encompassing Asia (n  20), Australasia (n  116), Brazil (n  2),
Burkina Faso (n  2; this study), Madagascar (n  3; this study), and Ecuador (n  1).
MLST. MLST of all of the isolates was performed either in silico from WGS data by exporting the
consensus sequence from the MLST loci with GATK (63) or by Sanger sequencing as previously described
(64).
WGS, variant identiﬁcation, and phylogenetic reconstruction. Genomic DNA was extracted from
the ﬁve African genomes as previously described (65). High-quality DNA was subjected to paired-end
WGS with the Illumina HiSeq2000 instrument and NextEra XT library preparation to an average depth of
65 (range, 50 to 80). Publicly available B. pseudomallei genomes were downloaded from NCBI and,
where required, converted to simulated Illumina reads with ART (version VanillaIceCream, 85 coverage,
paired-end and quality shifts of 10) (66). B. pseudomallei MSHR1655, a sequential isolate from a
chronic-carriage infection that has undergone genome reduction (61), was excluded from this analysis to
maximize core genome size; all of the other available genomes of acceptable quality were included. Core
genome, orthologous, biallelic SNPs were identiﬁed by GATK v3.1 (63) within the comparative genomics
pipeline SPANDx v2.7 (75) by using default parameters. The B. pseudomallei K96243 reference genome
(67) was used for read mapping by BWA v0.6.2 (68) (GenBank accession numbers BX571965 and
BX971966). Maximum-parsimony analyses were performed by a heuristic search with PAUP v4.0b10 (69).
Trees were bootstrapped in PAUP using 200 replicates.
16S-23S rDNA ITS typing. The ITS types of the ﬁve African isolates were determined from
whole-genome sequences. Brieﬂy, genomes were assembled with an in-house assembly pipeline (38) or
retrieved from the NCBI genome database. BLAST (70) was used to align the B. pseudomallei ITS types (E,
C, and G) against the assembled genomes. All of the alignments were manually inspected to determine
the ITS types. Where BLAST results were ambiguous (because multiple ITS types were present in a single
genome), short-read data were aligned against ITS types E, C, and G using SPANDx and alignments were
visually inspected with Tablet v1.15.08.25 (71) to determine the ITS type(s) and their allelic abundance.
Virulence gene and accessory gene screening. To assess the virulence potential of the ﬁve African
strains, we developed an in silico virulence gene panel comprising all known B. pseudomallei virulence
determinants (see reference 52 for a review). All of the genes in this panel are described in Table S2 in
the supplemental material. The tBLASTn (72) algorithm was used to assess amino acid identity. BLAST
matches were normalized by calculating the BSR (73) with B. pseudomallei K96243 as the control. A
standard BSR cutoff of 0.70 was applied to call a virulence factor present; loci with scores below this
cutoff were considered absent or highly variable. BRIG v0.95 (74) was used to visualize synteny and gene
presence or absence across the genome.
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Data availability. The whole-genome short-read data generated in this study are available in the
NCBI Sequence Read Archive under accession no. SRP067905. All of the ST proﬁles have been submitted
to and are available in the B. pseudomallei MLST database (http://pubmlst.org/bpseudomallei).
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at http://dx.doi.org/10.1128/
mSphere.00089-15.
Table S1, XLSX ﬁle, 0.02 MB.
Table S2, XLSX ﬁle, 0.1 MB.
Table S3, XLSX ﬁle, 0.01 MB.
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